Biotech News Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech News

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

From: tom pope	4/23/2012 8:21:10 PM
	of 7143

WSJ. Will paste full article if any interest. <> A growing number of patient-advocacy groups are playing matchmaker, linking patients to researchers who need them for clinical trials. The move comes as a persistent shortage of volunteers has slowed trials of new treatments for cancer and other diseases, which typically involve a patient receiving a drug or a placebo. People, including healthy volunteers, also are urgently needed for studies to contribute to the overall understanding of diseases including Parkinson's and Alzheimer's, experts say. The Michael J. Fox Foundation for Parkinson's Research on Tuesday is formally launching the Fox Trial Finder for patients with the disease, which the actor was diagnosed with in 1991 and affects about one million Americans. The Alzheimer's Association and JDRF, a Type 1 diabetes group formerly known as the Juvenile Diabetes Research Foundation, have launched matching sites, too. The National Multiple Sclerosis Society posts regular trial alerts. After it posted a study of an oral drug in January 2011, 188 people visited the study website in about a month and 146 took an online screening test to see if they qualified.<snip>

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next